Bruce Dorr, MD, FPMRS, FACOG, a Board-Certified ObGyn and Subspecialty Boarded in UroGynecology and Reconstructive Pelvic Surgery and Senior Medical Advisor at BioTe, talks to Well Woman Today about menopausal women who possess deleterious gene mutations like BRCA1/2 or PTEN and what they should know regarding Hormone Replacement Therapy. ...
Menopause
Well Woman Today strives to be the premier menopause resource for health care professionals committed to advancing the health and well-being of all women.
Advertisement
Women in their midlife using Hormone Replacement Therapy demonstrated a 32% lower dementia risk.
A new study revealed that cancers fueled by hormones like estrogen are most strongly linked to excess body fat.
By 2023, hormone therapy usage decreased among women aged 40 and older.
Studies have shown that menopause is associated with muscle loss and strength decline in women.
Studies have found that having both ovaries removed before natural menopause increases the risk of cognitive impairment.
Less than half women reported that their HCP counseled them on postmenopausal bleeding being a symptom of endometrial cancer.
After menopause, accelerated plaque buildup in women’s arteries rapidly increases their heart disease risk to match men's.
The skin of postmenopausal women who receive HRT is more prone to inflammation but also to self-repair.
Women who enter menopause before age 40 are twice as likely to die from heart disease.
“Women should know that hormone therapy is safe and beneficial.”
Scientists believe that hormones may contribute to these sex differences in susceptibility to lung cancer.
Women experiencing earlier menopause and higher vascular risk had lower cognitive scores.
Post-menopausal non-Hispanic Black women are more likely to experience weight gain than non-Hispanic white women.
The study revealed that Black, Asian, and Latina women on average begin menopause earlier than white women.
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.